Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Neoplasm Metastasis 5 Polycystic Ovary Syndrome 3 Advanced Breast Cancer 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Leiomyoma 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Recurrence 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma 1 Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms, Male 1 Breast Neoplasm Female 1 Breast Carcinoma In Situ 1 Advanced HR+/HER2- Breast Cancer 1

Interventions

venetoclax 1 palbociclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Neoplasm Female × Letrozole × Clear all

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡